Publication | Closed Access

2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma

Neuro-oncologyMedicinal ChemistryNovel InhibitorMedicineReceptor Tyrosine KinasePharmacological AgentAnti-cancer AgentHigh-grade GliomasCell BiologyCancer TreatmentPharmacologyGliomaDrug Discovery